Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results
Wednesday, September 28, 2022
VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)
Thursday, November 18, 2021
ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement
Tuesday, August 17, 2021
Pagination